Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New combo treatment could ease frozen shoulder pain faster

NCT ID NCT06229964

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at whether adding a nerve block to a standard steroid injection helps people with frozen shoulder feel less pain and move better. About 110 adults with frozen shoulder will get either the combo treatment or a steroid injection alone. The goal is to see if the nerve block provides extra relief for this often long-lasting condition.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 110 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

May 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 99 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Written informed consent to participate in the study must be obtained from the subject prior to initiation of any study-mandated procedure * Suffering from Frozen Shoulder, defined as: Frozen shoulder is a self-limiting disease characterized by pain and functional restriction in both active and passive shoulder motion lasting more than 1 month, for which radiographic findings of the shoulder joint are unremarkable. * Dutch or French speaking persons * Age ≥ 18 years Exclusion Criteria: * Subjects with posttraumatic or postsurgical stiff shoulder syndrome * History of trauma at the onset of symptoms * Subjects with rheumatologic or neurologic disease involving the shoulder * Subjects with cervical radiculopathy * Coagulation disorder * Hypersensitivity to local anesthetics or MRI contrast agent * Inability to understand the study procedures * Psychiatric illness * Pregnancy * Subjects who have received prior SSNB in the homolateral shoulder * Subjects who have received an IACI in the homolateral shoulder in the 3 months before inclusion• Systematic yeast infections * Hypovolaemia * Infections at the injection site * Medical history of malignant hyperthermia, major conduction disorders, acute cardiac decompensation, shock conditions, convulsions Control subjects for the diagnostic accuracy part of the study protocol * Inclusion criteria: * Written informed consent to participate in the study must be obtained from the sub-ject prior to initiation of any study-mandated procedure * Subjects suffering from shoulder pain that do not fulfill the diagnostic criteria of Frozen Shoulder * Dutch or French speaking persons * Age ≥ 18 years * Contralateral shoulder of Frozen Shoulder subjects * Exclusion criteria * Subjects with posttraumatic or postsurgical stiff shoulder syndrome * History of trauma at the onset of symptoms * Subjects with rheumatologic or neurologic disease involving the shoulder * Subjects with cervical radiculopathy * Coagulation disorder or treatments with anticoagulants * Hypersensitivity to MRI contrast agent * Inability to understand the study procedures * Psychiatric illness * Pregnancy * Systematic yeast infections * Hypovolaemia * Infections at the injection site * Medical history of malignant hyperthermia, major conductin disorders, acute cardi-ac decompensation, shock conditions, convulsions

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Adhesive capsulitis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Universitair Ziekenhuis Brussel

    RECRUITING

    Brussels, 1090, Belgium

More trials for these conditions

Other studies related to the condition(s) this trial covers.